Pharmacy nonprescription syringe distribution and HIV/AIDS: A review
Patrick Janulis
J Am Pharm Assoc (2003) 2012;52:787-797. doi:10.1331/JAPhA.2012.11136


Objective  To summarize current research findings on pharmacy nonprescription syringe distribution to prevent the spread of human immunodeficiency virus (HIV)/acquired immune deficiency syndrome (AIDS) among injection drug users (IDUs), including research on pharmacist attitudes and behavior, drug user attitudes and behavior, and the health impact on HIV/AIDS risk behavior.

Data sources  Data were collected using PubMed and PsycINFO through July 2011. Search terms used were pharmacist or pharmacy and syringe or syringe exchange or needle or needle exchange. Two journals (Journal of Urban Health and Journal of the American Pharmacists Association) with a high number of hits were manually inspected. Reference sections for each article also were examined.

Study selection  Studies were included if they examined attitudes toward, experiences with, or the impact of pharmacy nonprescription syringe distribution for the purpose of preventing the spread of HIV/AIDS among IDUs in the United States. Studies were excluded that mentioned these topics in passing or did not report empirical results.

Data synthesis  47 studies were identified that met the inclusion criteria. Studies included a diverse range of perspectives, including pharmacist viewpoints, IDU attitudes, and evaluations.

Conclusion  According to the available literature, many pharmacists express willingness to sell and report selling syringes to customers without a prescription. IDUs show willingness to use pharmacies to obtain syringes. Finally, pharmacy syringe sale and the legalization of this practice appear to have a positive impact on HIV risk behavior. Accordingly, the nonprescription sale of syringe should be promoted. However, the literature remains incomplete and future research is required.

Sign In
APhA Members 
Welcome to JAPhA.org! Please log in below using your APhA username and password. Update your APhA profile.
Not a Subscriber
New to JAPhA? Become an APhA member to receive a full subscription to both the print and online editions.


Register for a FREE limited account to benefit from personalization features such as alerts.


Mehta SH, Astemborski J, Kirk GD, et al.  Changes in blood-borne infection risk among injection drug users.  J Infect Dis.  2011;203:587–94.[PubMed]
Heller D, Paone D, Siegler A, Karpati A.  The syringe gap: an assessment of sterile syringe need and acquisition among syringe exchange program participants in New York City.  Harm Reduct J.  2009;6:1.[PubMed]
Taussig JA, Weinstein B, Burris S, Jones T.  Syringe laws and pharmacy regulations are structural constraints on HIV prevention in the US.  AIDS.  2000;14:S47–51.[PubMed]
Cooper HL, Jarlais DC Des, Ross Z, et al.  Spatial access to syringe exchange programs and pharmacies selling over-the-counter syringes as predictors of drug injectors’ use of sterile syringes.  Am J Public Health.  2011;101:1118–25.[PubMed]
Burris S.  Nonprescription access to sterile syringes: the Project on Harm Reduction in the Health Care System: 2009. Accessed at www.temple.edu/lawschool/phrhcs/otc.htm,  August 1, 2011.
Deas C, McCree DH.  Pharmacists and HIV/AIDS prevention: review of the literature.  J Am Pharm Assoc.  2010;50:411–5.
Nacopoulos AG, Lewtas AJ, Ousterhout MM.  Syringe exchange programs: impact on injection drug users and the role of the pharmacist from a U.S. perspective.  J Am Pharm Assoc.  2010;50:148–57.
Zaller N, Jeronimo A, Bratberg J, et al.  Pharmacist and pharmacy staff experiences with non-prescription (NP) sale of syringes and attitudes toward providing HIV prevention services for injection drug users (IDUs) in Providence, RI.  J Urban Health.  2010;87:942–53.[PubMed]
Tesoriero J, Battles H, Klein S, et al.  Expanding access to sterile syringes through pharmacies: assessment of New York's Expanded Syringe Access Program.  J Am Pharm Assoc.  2009;49:407–16.
Klein S, Harris-Valente K, Candelas A, et al.  What do pharmacists think about New York State's new nonprescription syringe sale program? Results of a survey.  J Urban Health.  2001;78:679–89.[PubMed]
Coffin P, Linas B, Factor S, Vlahov D.  New York City pharmacists’ attitudes toward sale of needles/syringes to injection drug users before implementation of law expanding syringe access.  J Urban Health.  2000;77:781–93.[PubMed]
Coffin P, Ahern J, Dorris S, et al.  More pharmacists in high-risk neighborhoods of New York City support selling syringes to injection drug users.  J Am Pharm Assoc.  2002;42:62–7.
Linas B, Coffin P, Backes G, Vlahov D.  New York State pharmacists’ attitudes toward needle and syringe sales to injection drug users before implementation of syringe deregulation.  J Urban Health.  2000;77:768–80.[PubMed]
Deibert R, Goldbaum G, Parker T, et al.  Increased access to unrestricted pharmacy sales of syringes in Seattle-King County, Washington: structural and individual-level changes, 1996 versus 2003.  Am J Public Health.  2006;96:1347–53.[PubMed]
Lewis B, Koester S, Bush T.  Pharmacists’ attitudes and concerns regarding syringe sales to injection drug users in Denver, Colorado.  J Am Pharm Assoc.  2002;42:46–51.
Taussig JA, Junge B, Burris S, et al.  Individual and structural influences shaping pharmacists’ decisions to sell syringes to injection drug users in Atlanta, Georgia.  J Am Pharm Assoc.  2002;42:40–5.
Reich W, Compton W, Horton J, et al.  Pharmacist ambivalence about sale of syringes to injection drug users.  J Am Pharm Assoc.  2002;42:52–7.
Blumenthal W, Springer K, Jones T, Sterk C.  Pharmacy student knowledge, attitudes, and beliefs about selling syringes to injection drug users.  J Am Pharm Assoc.  2002;42:34–9.
Gleghorn A, Gee G, Vlahov D.  Pharmacists’ attitudes about pharmacy sale of needles/syringes and needle exchange programs in a city without needle/syringe prescription laws.  J Acquir Immune Defic Syndr Hum Retrovirol.  1998;18(suppl 1):S89–93.[PubMed]
Reich W, Compton W, Horton J, et al.  Injection drug users report good access to pharmacy sale of syringes.  J Am Pharm Assoc.  2002;42:68–72.
Singer M, Baer H, Scott G, et al.  Pharmacy access to syringes among injecting drug users: follow-up findings from Hartford, Connecticut.  Public Health Rep.  1998;113(suppl 1):81–9.[PubMed]
Junge B, Vlahov D, Riley E, et al.  Pharmacy access to sterile syringes for injection drug users: attitudes of participants in a syringe exchange program.  J Am Pharm Assoc.  1999;39:17–22.
Compton WM, Horton JC, Cottler LB, et al.  A multistate trial of pharmacy syringe purchase.  J Urban Health.  2004;81:661–70.[PubMed]
Battles H, Rowe K, Ortega-Peluso C, et al.  Who purchases nonprescription syringes? Characterizing customers of the Expanded Syringe Access Program (ESAP).  J Urban Health.  2009;86:946–50.[PubMed]
Zaller N, Yokell M, Jeronimo A, et al.  Adverse event associated with a change in nonprescription syringe sale policy.  J Am Pharm Assoc.  2010;50:619–22.
Fisher D, Fenaughty A, Cagle H, Reynolds G.  Injection drug users’ use of pharmacies for purchasing needles in Anchorage, Alaska.  Int J Drug Policy.  2003;14:381–7.
Costenbader E, Zule W, Coomes C.  Racial differences in acquisition of syringes from pharmacies under conditions of legal but restricted sales.  Int J Drug Policy.  2010:425–8.
Fuller C, Galea S, Blaney S, et al.  Explaining the relationship between race/ethnicity and pharmacy purchased syringes among injection drug users in New York City.  Ethn Dis.  2004;14:589–96.[PubMed]
Riley ED, Kral AH, Stopka TJ, et al.  Access to sterile syringes through San Francisco pharmacies and the association with HIV risk behavior among injection drug users.  J Urban Health.  2010;87:534–42.[PubMed]
Rudolph A, Crawford N, Ompad D, et al.  Comparison of injection drug users accessing syringes from pharmacies, syringe exchange programs, and other syringe sources to inform targeted HIV prevention and intervention strategies.  J Am Pharm Assoc.  2010;50:140–7.
Deren S, Cleland C, Fuller C, .  The impact of syringe deregulation on sources of syringes for injection drug users: preliminary findings.  AIDS Behav.  2006;10:717–21.[PubMed]
Singer M, Himmelgreen D, Weeks M, et al.  Changing the environment of AIDS risk: findings on syringe exchange and pharmacy sales of syringes in Hartford, CT.  Med Anthropol.  1997;18:107–30.[PubMed]
Jarlais DC Des, McKnight C, Friedmann P.  Legal syringe purchases by injection drug users, Brooklyn and Queens, New York City, 2000–2001.  J Am Pharm Assoc.  2002;42(suppl 2):S73–6.
Compton WM, Cottler LB, Decker SH, et al.  Legal needle buying in St. Louis.  Am J Public Health.  1992;82:595–6.[PubMed]
Cooper HL, Bossak BH, Tempalski B, et al.  Temporal trends in spatial access to pharmacies that sell over-the-counter syringes in New York City health districts: relationship to local racial/ethnic composition and need.  J Urban Health.  2009;86:929–45.[PubMed]
Harbke C, Fisher D, Cagle H, et al.  Telephone survey of Alaskan pharmacists’ nonprescription needle-selling practices.  J Urban Health.  2000;77:113–20.[PubMed]
Valleroy L, Weinstein B, Jones T, et al.  Impact of increased legal access to needles and syringes on community pharmacies’ needle and syringe sales-Connecticut, 1992–1993.  J Acquir Immune Defic Syndr Hum Retrovirol.  1995;10:73–81.[PubMed]
Finkelstein R, Tiger R, Greenwald R, Mukherjee R.  Pharmacy syringe sale practices during the first year of expanded syringe availability in New York City (2001–2002).  J Am Pharm Assoc.  2002;42:83–7.
Koester S, Lewis B, Bush T.  Limited access to syringes for injection drug users in pharmacies in Denver, Colorado.  J Am Pharm Assoc.  2002;42:88–91.
Cooper EN, Dodson C, Stopka TJ, et al.  Pharmacy participation in non-prescription syringe sales in Los Angeles and San Francisco Counties, 2007.  J Urban Health.  2010;87:543–52.[PubMed]
Fuller C, Ahern J, Vadnai L, et al.  Impact of increased syringe access: preliminary findings on injection drug user syringe source, disposal, and pharmacy sales in Harlem, New York.  J Am Pharm Assoc.  2002;42:77–82.
Stopka T, Garfein R, Ross A, Truax S.  Increasing syringe access and HIV prevention in California: findings from a survey of local health jurisdiction key personnel.  J Urban Health.  2007;84:116–25.[PubMed]
Garfein RS, Stopka TJ, Pavlinac PB, et al.  Three years after legalization of nonprescription pharmacy syringe sales in California: where are we now? J Urban Health.  2010;87:576–85.[PubMed]
Rose V, Raymond H.  Evaluation of nonprescription syringe sales in San Francisco.  J Am Pharm Assoc.  2010;50:595–9.
Backes G, Rose VJ.  Primary and secondary analysis of local elected officials’ decisions to support or oppose pharmacy sale of syringes in California.  J Urban Health.  2010;87:553–60.[PubMed]
Cotten-Oldenburg NU, Carr P, DeBoer JM, et al.  Impact of pharmacy-based syringe access on injection practices among injecting drug users in Minnesota, 1998 to 1999.  J Acquir Immune Defic Syndr.  2001;27:183–92.[PubMed]
Groseclose SL, Weinstein B, Jones TS, et al.  Impact of increased legal access to needles and syringes on practices of injecting-drug users and police officers: Connecticut, 1992–1993.  J Acquir Immune Defic Syndr Hum Retrovirol.  1995;10:82–9.[PubMed]
Deren S, Fuller C, Pouget E, et al.  Impact of expanding syringe access in New York on sources of syringes for injection drug users in Harlem and the Bronx, NYC, USA.  Int J Drug Policy.  2003;14:373–9.
Pouget ER, Deren S, Fuller CM, et al.  Receptive syringe sharing among injection drug users in Harlem and the Bronx during the New York State Expanded Syringe Access Demonstration Program.  J Acquir Immune Defic Syndr.  2005;39:471–7.[PubMed]
Jarlais DC Des, McKnight C, Goldblatt C, Purchase D.  Doing harm reduction better: syringe exchange in the United States.  Addiction.  2009;104:1441–6.[PubMed]
Rudolph AE, Standish K, Amesty S, et al.  A community-based approach to linking injection drug users with needed services through pharmacies: an evaluation of a pilot intervention in New York City.  AIDS Educ Prev.  2010;22:238–51.[PubMed]
Wolfe T, Amelunxen V, Torres D, et al.  Encouraging pharmacy sale of syringes to injection drug users in New Mexico.  J Am Pharm Assoc.  2002;42(suppl 2):S32–3.
Fuller CM, Galea S, Caceres W, et al.  Multilevel community-based intervention to increase access to sterile syringes among injection drug users through pharmacy sales in New York City.  Am J Public Health.  2007;97:117–24.[PubMed]
Rose V, Backes G, Martinez A, McFarland W.  Non-prescription syringe sales in California: a qualitative examination of practices among 12 local health jurisdictions.  J Urban Health.  2010;87:561–75.[PubMed]
Crawford ND, Blaney S, Amesty S, et al.  Individual- and neighborhood-level characteristics associated with support of in-pharmacy vaccination among ESAP-registered pharmacies: pharmacists’ role in reducing racial/ethnic disparities in influenza vaccinations in New York City.  J Urban Health.  2011;88:176–85.[PubMed]
J O’Loughlin, Masson P, Déry V, Fagnan D.  The role of community pharmacists in health education and disease prevention: a survey of their interests and needs in relation to cardiovascular disease.  Prev Med.  1999;28:324–31.[PubMed]
Ashley MJ, Brewster JM, Victor JC.  Pharmacists’ smoking cessation practices: relationship to their knowledge and skills, attitudes, and perceptions of roles.  J Am Pharm Assoc.  2006;46:729–37.
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Please read the other comments before you post yours. Comments are moderated and will appear on the site at the discertion of the editorial staff.
* = Required Field
(if multiple authors, separate names by comma)
Example: John Doe

Related Content

Customize your page view by dragging & repositioning the boxes below.

JAPhA Articles
Topic Collections
PubMed Articles
  • Print
  • PDF Download
  • Email
  • Share
  • Get Citation
  • Submit Comment
  • Article Alerts
    Please Wait... Processing your request... Please Wait.
    You must sign in to sign-up for alerts.

    Please confirm that your email address is correct, so you can successfully receive this alert.

  • Letters To Editor
  • Reprints